Browse the detailed record of transactions filed by 한상철, Chairman & CEO. Director active across 2 companies, notably 온코닉테라퓨틱스. In total, 17,943 filings have been logged. History available since 4 March 2026. The latest transaction was filed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is free.
Han Sang-cheol is the Chairman & CEO of Onconic Therapeutics, where he leads the company in developing innovative therapeutic solutions. With significant experience in the industry, he is responsible for overall strategy and operational direction. Han Sang-cheol is recognized for his ability to establish strategic partnerships and guide the company toward growth.